<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T08:02:31Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/94488" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/94488</identifier><datestamp>2024-08-08T00:06:38Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro</dc:title>
   <dc:creator>De Tapia Hernández, Lidia Consuelo</dc:creator>
   <dc:creator>García-Fojeda García-Valdecasas, María Belén</dc:creator>
   <dc:creator>Kronqvist, Nina</dc:creator>
   <dc:creator>Johansson, Jan</dc:creator>
   <dc:creator>Casals Carro, María Cristina</dc:creator>
   <dc:subject>577.1</dc:subject>
   <dc:subject>Cathelicidin LL-37</dc:subject>
   <dc:subject>Collectin SP-A</dc:subject>
   <dc:subject>Trimeric recombinant fragment</dc:subject>
   <dc:subject>Antimicrobial activity</dc:subject>
   <dc:subject>Cytotoxicity</dc:subject>
   <dc:subject>Inflammation</dc:subject>
   <dc:subject>P2X7 channel</dc:subject>
   <dc:subject>Alveolar epithelial cells</dc:subject>
   <dc:subject>Bioquímica (Biología)</dc:subject>
   <dc:subject>2403 Bioquímica</dc:subject>
   <dc:description>Human cathelicidin (LL-37) is a defense peptide with antimicrobial activity against various pathogens. However, LL-37 can also trigger tissue injury by binding to host cell membranes. The cytotoxic effects of LL-37 may be especially relevant in chronic respiratory diseases characterized by increased LL-37. The aim of this study was to investigate whether the human collectin SP-A and a trimeric recombinant fragment thereof (rfhSP-A) can regulate the activities of LL-37. To this end, we studied the interaction of LL-37 with SP-A and rfhSP-A by intrinsic fluorescence, dynamic light scattering, and circular dichroism, as well as the effects of these proteins on the antimicrobial and cytotoxic activities of LL-37. Both SP-A and rfhSP-A bound LL-37 with high affinity at physiological ionic strength ( 0.45 ± 0.01 nM for SP-A and 1.22 ± 0.7 nM for rfhSP-A). Such interactions result in the reduction of LL-37-induced cell permeability and IL-8 release in human pneumocytes, mediated by P2X7 channels. Binding of LL-37 to SP-A did not modify the properties of SP-A or the antibacterial activity of LL-37 against respiratory pathogens (Pseudomonas aeruginosa, and nontypeable Haemophilus influenzae). SP-A/LL-37 complexes showed a greater ability to aggregate LPS vesicles than LL-37, which reduces endotoxin bioactivity. These results reveal the protective role of native SP-A in controlling LL-37 activities and suggest a potential therapeutic effect of rfhSP-A in reducing the cytotoxic and inflammatory actions of LL-37, without affecting its microbicidal activity against Gram-negative pathogens.</dc:description>
   <dc:description>Ministerio de Ciencia e Innovación (España)</dc:description>
   <dc:description>Comunidad de Madrid</dc:description>
   <dc:description>Swedish Research Council</dc:description>
   <dc:description>Depto. de Bioquímica y Biología Molecular</dc:description>
   <dc:description>Fac. de Ciencias Químicas</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2024-01-22T16:20:47Z</dc:date>
   <dc:date>2024-01-22T16:20:47Z</dc:date>
   <dc:date>2022</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/94488</dc:identifier>
   <dc:identifier>1664-3224</dc:identifier>
   <dc:identifier>10.3389/fimmu.2022.994328</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>PID2021-123044OB-I00</dc:relation>
   <dc:relation>PEJ-2020-AI/BMD-17865</dc:relation>
   <dc:relation>Swedish Research Council 2020–02434</dc:relation>
   <dc:relation>de Tapia L, García-Fojeda B, Kronqvist N, Johansson J and Casals C (2022) The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro. Front. Immunol. 13:994328. doi: 10.3389/fimmu.2022.994328</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Frontiers</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>